OkategoriseradeBioProcess International 2023 Scientific Track Presentation Boston

Next-generation bioprocessing strategies to improve speed, cost and quality of tech transfer

Hear Marc Smith speak to learn how an innovative tech transfer approach can enable consistent and compliant processes, increase efficiency, reduce costs and revolutionize drug manufacturing in the pharmaceutical industry. 

Tech transfer is a critical yet challenging element of drug development and manufacturing

Presented at BioProcess International in Boston, by Marc Smith, Director of Strategic Solutions at IDBS.

Transferring product, process and equipment knowledge between R&D and manufacturing teams is complex, expensive and time-consuming, costing several million dollars and taking 18 to 30 months. 

To address the tech transfer challenges that can delay or inhibit successful process scale-up, there is a need to rethink how the process description is controlled from the very start of process development, through process characterization and optimization, and ultimately on to manufacturing. 

Explore how taking a holistic perspective can address key pain points, such as process standardization, design consistency, compliance and communication between R&D and manufacturing teams. This approach, facilitated by a digital data backbone and analytics engine that shares data and knowledge across the BioPharma lifecycle, helps to control the creation and development of the process description, automate experiment generation, facilitate structured experimental execution, integrate DoE, and by using industry-standard formats, streamline the transfer of the process description to manufacturing.  

Watch On-Demand Now

Meet the team

Marc Smith headshot

Marc Smith

Director of Strategic Solutions, IDBS

Marc is the Director of Strategic Solutions and is accountable for the development of the IDBS Polar BPLM platform and associated Solutions. Marc is an expert in laboratory and operational technology, laboratory informatics and system integration and leads a team of technological and domain experts committed to the development of the Polar Solutions. He has over 15 years of experience working in the pharmaceutical sector implementing and leading digital solutions and strategies. Before joining IDBS in 2021, he worked at Lonza Biologics and Angel Biotechnology.  He holds a BSc (Hons) in Pharmacology from the University of Sunderland. 

More webinars